000			04230cam a2200613Mi 4500
001			ocn874146249
003			OCoLC
005			20221128212529.0
006			m d
007			cr cn|||||||||
008			090819s2010 enka ob 001 0 eng d
040			_aE7B _beng _erda _epn _cE7B _dOCLCO _dN$T _dYDXCP _dIDEBK _dEBLCP _dOCLCQ
019			_a868069186 _a869435448 _a923424667
020			_a9781908986597 _q(e-book)
020			_a190898659X _q(e-book)
020			_z9781903378717
020			_z1903378710
035			_a(OCoLC)874146249 _z(OCoLC)868069186 _z(OCoLC)869435448 _z(OCoLC)923424667
060		4	_a2010 I-616
060		4	_aWD 200.5.H8 _bE93 2010
060		4	_aWD 200.5.H8
072		7	_aHEA _x039000 _2bisacsh
072		7	_aMED _x014000 _2bisacsh
072		7	_aMED _x022000 _2bisacsh
072		7	_aMED _x112000 _2bisacsh
072		7	_aMED _x045000 _2bisacsh
049			_aMAIN
245	0	0	_aEvidence-based management of lipid disorders _c _h[E-Book]
264		1	_aHarley : _bTFM, _c2010.
300			_a1 online resource (326 pages) : _billustrations (chiefly color)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
504			_aIncludes bibliographical references and index.
588	0		_aPrint version record.
505	0		_aHow much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Despr�es -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.
650		0	_aLipids _xMetabolism _xDisorders _xTreatment.
650		0	_aEvidence-based medicine.
650	1	2	_aLipid Metabolism Disorders _xtherapy.
650	2	2	_aEvidence-Based Medicine.
650		4	_aEvidence-based medicine.
650		4	_aLipids _xMetabolism _xDisorders _xTreatment.
700	1		_aVissers, Maud N.
700	1		_aKastelein, John J. P.
700	1		_aStroes, Erik S.
856	4	0	_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=685402 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938			_aEBL - Ebook Library _bEBLB _nEBL3410357
938			_aebrary _bEBRY _nebr10827988
938			_aEBSCOhost _bEBSC _n685402
938			_aIngram Digital eBook Collection _bIDEB _ncis27569286
938			_aYBP Library Services _bYANK _n11574740
942			_n0
994			_a92 _bN$T
999			_c91620 _d91620